TrialEuropean urology2015

A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802.

Robert S DiPaola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.